RecallDepth
Class II Ongoing

Carvedilol Tablets USP, 12.5 mg, 100- Tablets, (10x10) cartons, Rx Only, Packaged and distributed by Major Pharmaceuticals, Indianapolis, IN, 46268, USA, NDC 0904-7307-61

This recall is currently active, issued August 27, 2025. It was issued by The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories.

Company
The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories
Recall Initiated
August 20, 2025
Posted
August 27, 2025
Recall Number
D-0594-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
26,628 cartons
Firm Location
La Vergne, TN, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm

Distribution

Product was distributed nationwide within the United States.

Lot / Code Info

Lot #: T05693, Exp. Date 03/2026

More recalls by The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories

View all recalls by this company →

Other recent Class II Drug recalls